De-escalation of P2Y12 Inhibitor Use After Percutaneous Coronary Intervention and Acute Coronary Syndromes by Quinton Barry, BMBS, FRCPC, Angel Fu, MD, FRCPC, Rene Boudreau, MD, FRCPC, Alyssa Chow, BSc, Cole Clifford, BSc, Trevor Simard, MD, FRCPC, Aun Yeong Chong, MBBS, FRCPC, Alexander Dick, MD, FRCPC, Michael Froeschl, MD, FRCPC, Christopher Glover, MD, FRCPC, Benjamin Hibbert, MD, FRCPC, Marino Labinaz, MD, FRCPC, Michel Le May, MD, FRCPC, FACC, Juan Russo, MD, FRCPC, Derek So, MD, FRCPC, FACC

Get full text

Modifiable Risk Factors and Residual Risk Following Coronary Revascularization by Trevor Simard, MD, Richard G. Jung, PhD, Pietro Di Santo, MD, David T. Harnett, MD, MSc, Omar Abdel-Razek, MD, F. Daniel Ramirez, MD, MSc, Pouya Motazedian, MD, Simon Parlow, MD, Alisha Labinaz, BSc, Robert Moreland, MD, Jeffrey Marbach, MBBS, MS, Anthony Poulin, MD, Amos Levi, MD, Kamran Majeed, MD, Paul Boland, MD, PhD, Etienne Couture, MD, Kiran Sarathy, MD, Steven Promislow, MD, Juan J. Russo, MD, Aun Yeong Chong, MD, Derek So, MD, Michael Froeschl, MD, Alexander Dick, MD, Marino Labinaz, MD, Michel Le May, MD, David R. Holmes, Jr., MD, Benjamin Hibbert, MD, PhD

Get full text